Sunshield Chemicals Ltd

Financial results and audit

• Approved unaudited quarterly results for quarter ended 30 June 2026.
• Limited Review Reports attached; auditors issued an unmodified report.
• Trading window opens 48 hours after declaration of results.

Meeting Details

• Board meeting on 11 August 2026; time and venue not disclosed.

Key Agenda Items

• Consider and take on record unaudited quarterly financial results for the quarter ended 30 June 2026.

Other Notes

• Trading window closed for designated persons and their immediate relatives till 13 August 2026.

Independent director reappointment

• Reason: Reappointment of Cyrus Poonevala as Independent Director.
• Date and term: Effective 15 January 2027 for five years.
• Profile and disclosures: 30+ years in aviation; not related to directors; not debarred.

AGM details

• AGM held on 3 July 2026 via VC/OVAM.
• Meeting ran from 11:00 AM to 11:57 AM.
• Record date: 26 June 2026.
• Total shareholders on record: 5,434.

Resolutions and outcomes

• Resolution 1: Adopt Audited Financial Statements for year ended 31 March 2026; Passed.
• Resolution 2: Declare final dividend on equity shares; Passed.
• Resolution 3: Re-appointment of Dr. Anand Parihar, retiring by rotation; Passed.
• Resolution 4: Ratification of remuneration to Cost Auditor for FY 2026-27; Passed.
• Resolution 5: Re-appointment of Cyrus Poonevala as Independent Director for second five-year term (2027–2032); Special; Passed.

Appointments and remuneration

• Dr. Anand Parihar re-appointed as Director, retiring by rotation.
• Cyrus Poonevala re-appointed as Independent Director for 2027–2032 term.
• Remuneration of Cost Auditor Kishore Bhatia & Associates ratified for FY 2026-27.

AGM Details

• Date and time: 3 July 2026, 11:00 IST
• Mode: VC/OAVM
• Quorum counted via VC/OAVM

Resolutions

• Adoption of financial statements and reports — Ordinary
• Dividend approved for FY ended 31 March 2026 — Ordinary
• Re-appointment of retiring director Dr. Anand Parihar — Ordinary
• Remuneration ratification for Cost Auditors for FY2027 — Ordinary
• Reappointment of Cyrus Poonevala as Independent Director — Special

Voting Results

• Poll results to be disclosed to stock exchange within two working days

Director Changes

• Dr. Anand Parihar re-appointed as Director
• Cyrus Poonevala re-appointed as Independent Director

Auditor Appointments

• Cost Auditor remuneration ratified for FY2027

AGM details

• 39th AGM on 3 July 2026 at 11:00 a.m. IST.
• To be held through VC/OAVM.
• Cut-off date for e-voting: 26 June 2026.
• Record date for final dividend: 11 June 2026.

Resolutions

• Ordinary: adopt audited financial statements for FY2025-26.
• Ordinary: declare final dividend of Rs. 3 per equity share.
• Ordinary: reappoint Dr. Anand Parihar, retiring by rotation.
• Ordinary: ratify cost auditor remuneration for FY2026-27.
• Special: reappoint Mr. Cyrus Poonevala as Independent Director for five years.

Voting outcome

• This chunk contains the notice, not the voting results.
• No resolution outcomes or approval percentages are disclosed here.

Dividend

• Final dividend recommended and proposed: Rs. 3 per equity share.
• Dividend payment targeted on or before 1 August 2026, if approved.

Director changes

• Dr. Anand Parihar proposed for reappointment as director liable to retire by rotation.
• Mr. Cyrus Poonevala proposed for second five-year independent director term from 15 January 2027.
• Mr. Ajit Shah ceased as independent director on 19 October 2025.

Auditors

• Cost auditor M/s Kishore Bhatia & Associates proposed for FY2026-27.
• Proposed cost audit remuneration: Rs. 3,00,000 plus taxes and expenses.
• Statutory auditors are CNK & Associates LLP, continuing from prior AGM appointment.

Related party transactions

• No material related party transactions were reported.
• Related-party dealings were stated to be at arm’s length and disclosed in notes.

Other approvals

• Rights issue completed during the year, raising Rs. 12,990.41 lakhs gross.
• Rights proceeds used mainly to repay borrowings and fund general corporate purposes.
• No stock option scheme was in place.
• CSR spending for FY2025-26 was Rs. 43.35 lakhs, slightly above requirement.

AGM details

• 39th AGM scheduled for 3 July 2026 at 11:00 a.m. IST.
• Meeting to be held through VC/OAVM.

Ordinary business

• Adoption of audited financial statements for year ended 31 March 2026.
• Dividend of ₹3 per equity share proposed.
• Dr. Anand Parihar proposed for re-appointment by rotation.

Special business

• Ratification of ₹3,00,000 remuneration to cost auditors for FY2027.
• Re-appointment of Mr. Cyrus Poonevala as independent director for five years.

Director changes

• Dr. Anand Parihar continues as non-executive director, liable to retire by rotation.
• Mr. Cyrus Poonevala to serve second five-year independent director term from 15 January 2027.
• Independent director fees and sitting fees to continue as applicable.

Auditor matters

• M/s Kishore Bhatia & Associates appointed as cost auditors for FY2027.
• Remuneration approved at ₹3,00,000 plus taxes and out-of-pocket expenses.

Voting and approvals

• Resolutions were proposed for shareholder approval at the AGM.
• No voting results are reported in this chunk.